Several changes agree with our results (increased glutamine, creatine, lactate, and glycine in cancer), but they also found decreased levels of BCAA, lysine, tyrosine, and phenylalamnine in the malignant samples compared to the benign tumors. This evidence concerns the gene ARID4B and benign neoplasm.